AR019477A1 - Triazolopiridinas para el tratamiento de los trastornos de la trombosis - Google Patents

Triazolopiridinas para el tratamiento de los trastornos de la trombosis

Info

Publication number
AR019477A1
AR019477A1 ARP990103671A ARP990103671A AR019477A1 AR 019477 A1 AR019477 A1 AR 019477A1 AR P990103671 A ARP990103671 A AR P990103671A AR P990103671 A ARP990103671 A AR P990103671A AR 019477 A1 AR019477 A1 AR 019477A1
Authority
AR
Argentina
Prior art keywords
treatment
triazolopiridins
gpiib
methods
thrombosis disorders
Prior art date
Application number
ARP990103671A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR019477A1 publication Critical patent/AR019477A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

La invencion se dirige a nuevos derivados de triazolopiridina que resultan de utilidad como antagonistas de la GPIIb/IIIa. También se revelan lascomposiciones farmacéuticas que comprenden los derivados de triazolopiridina de la presente invencion, los métodos para el tratamiento de las condicionesmediadas por la GPIIb/IIIa (por ejemplo, los métodos destinados al tratamiento de los trastornos tromboticos mediados por las plaquetas), junto con losprocesos de fabricacion de los compuestos y los nuevos intermediarios.
ARP990103671A 1998-07-27 1999-07-26 Triazolopiridinas para el tratamiento de los trastornos de la trombosis AR019477A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9423198P 1998-07-27 1998-07-27
US09/354,032 US6303625B1 (en) 1998-07-27 1999-07-15 Triazolopyridines for the treatment of thrombosis disorders

Publications (1)

Publication Number Publication Date
AR019477A1 true AR019477A1 (es) 2002-02-20

Family

ID=22243910

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103671A AR019477A1 (es) 1998-07-27 1999-07-26 Triazolopiridinas para el tratamiento de los trastornos de la trombosis

Country Status (21)

Country Link
US (1) US6303625B1 (es)
EP (1) EP1102766B1 (es)
JP (1) JP2003527306A (es)
KR (1) KR20010079576A (es)
CN (1) CN1320125A (es)
AR (1) AR019477A1 (es)
AT (1) ATE263169T1 (es)
AU (1) AU757512B2 (es)
BR (1) BR9912556A (es)
CA (1) CA2338654A1 (es)
CZ (1) CZ2001347A3 (es)
DE (1) DE69916073T2 (es)
ES (1) ES2219042T3 (es)
HU (1) HUP0103832A3 (es)
ID (1) ID27214A (es)
MX (1) MXPA01001099A (es)
NO (1) NO20010456L (es)
PL (1) PL345769A1 (es)
SK (1) SK1342001A3 (es)
WO (1) WO2000006570A1 (es)
ZA (1) ZA200100783B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306909B1 (en) 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
CZ2002518A3 (cs) * 1999-08-13 2002-05-15 Biogen, Inc. Inhibitory buněčné adheze a farmaceutické prostředky, které je obsahují
TWI290136B (en) * 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
JP2004536071A (ja) * 2001-05-25 2004-12-02 クイーンズ　ユニバーシティ　アット　キングストン 複素環ベータアミノ酸およびそれらの抗癲癇誘発剤としての使用
WO2003000657A1 (fr) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Derives de diamine
WO2006018727A2 (en) * 2004-08-18 2006-02-23 Pharmacia & Upjohn Company Llc Triazolopyridine compounds useful for the treatment of inflammation
US7618983B2 (en) * 2004-11-10 2009-11-17 Janssen Pharmaceutica, N.V. Bicyclic triazole α4 integrin inhibitors
HUE029336T2 (en) * 2005-09-16 2017-02-28 Daiichi Sankyo Co Ltd For the preparation of an optically active diamine derivative and process
WO2008045393A2 (en) * 2006-10-11 2008-04-17 Amgen Inc. Imidazo- and triazolo-pyridine compounds and methods of use therof
EP2417135A1 (en) * 2009-04-07 2012-02-15 Schering Corporation Substituted triazolopyridines and analogs thereof
US8871760B2 (en) * 2009-09-21 2014-10-28 Roche Palo Alto Llc [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
MX339302B (es) 2011-09-15 2016-05-19 Novartis Ag 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como cinasas de tirosina.
EP3004095A1 (de) * 2013-06-03 2016-04-13 Bayer Pharma Aktiengesellschaft Triazolopyridine als thrombininhibitoren zur behandlung von thromboembolischen erkrankungen
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050525A (en) 1960-12-14 1962-08-21 John B Bicking Certain derivatives of s-triazolo [4, 3-a]-pyridine
NZ262664A (en) 1993-02-22 1997-04-24 Merck & Co Inc Heterocyclic substituted derivatives, and medicaments thereof
DE4326758A1 (de) * 1993-08-10 1995-02-16 Basf Ag [1,3,4]Triazolo[1,5-a]pyridine
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists

Also Published As

Publication number Publication date
JP2003527306A (ja) 2003-09-16
EP1102766A1 (en) 2001-05-30
WO2000006570A1 (en) 2000-02-10
ES2219042T3 (es) 2004-11-16
AU5221899A (en) 2000-02-21
PL345769A1 (en) 2002-01-02
HUP0103832A3 (en) 2002-12-28
CZ2001347A3 (cs) 2001-12-12
HUP0103832A2 (hu) 2002-04-29
US6303625B1 (en) 2001-10-16
ZA200100783B (en) 2002-01-28
NO20010456D0 (no) 2001-01-26
SK1342001A3 (en) 2002-04-04
ID27214A (id) 2001-03-08
DE69916073D1 (de) 2004-05-06
NO20010456L (no) 2001-03-26
CN1320125A (zh) 2001-10-31
DE69916073T2 (de) 2004-12-30
CA2338654A1 (en) 2000-02-10
AU757512B2 (en) 2003-02-20
ATE263169T1 (de) 2004-04-15
MXPA01001099A (es) 2002-04-24
EP1102766B1 (en) 2004-03-31
KR20010079576A (ko) 2001-08-22
BR9912556A (pt) 2002-01-15

Similar Documents

Publication Publication Date Title
AR019477A1 (es) Triazolopiridinas para el tratamiento de los trastornos de la trombosis
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
PA8693101A1 (es) Compuestos de isoindol-imida y composiciones que los incluyen y mètodos para su uso
NI200300025A (es) Derivados de nicotinamida utiles como inhibidores de pde4.
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
AR023129A1 (es) Composiciones para mejorar la fertilidad
BRPI0512690A (pt) análogos de fosfonato de compostos inibidores de hiv
DOP2003000566A (es) Cicloalcanindoles con sustitución con fluor, composiciones que contienen estos compuestos y metodos de preparación para un medicamento
PA8596901A1 (es) Inhibidores de p38 y metodos de uso de ellos
PA8541801A1 (es) Inhibidores de aldosa reductasa del grupo de las piridazinonas
ECSP034428A (es) Ciclopentanoindoles, composiciones conteniendo tales compuestos y su uso
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2184070T3 (es) Derivados de oximas sustituidas utiles como antagonistas de la neuroquinina.
DOP2006000017A (es) Pirazolopiridinas y sales de las mismas, una composición farmaceútica que comprende dichos compuestos, un método para prepararlos y su uso
DOP2002000545A (es) Moléculas pequeñas para el tratamiento del crecimiento celular anormal
GT200500330A (es) Derivados de quinolina e isoquinolina 5-sustituidos, un prodecimiento para su preparacion y su uso como inhibidores de la inflamacion
PE20231073A1 (es) Inhibidores de pi3k y metodos de uso de los mismos
PA8654701A1 (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
UY27657A1 (es) Derivados de nicotinamida útiles como inhibidores de pde4
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
ECSP056106A (es) Compuestos novedosos de acido fosfonico como inhibidores de las serina proteasas
PA8591901A1 (es) Derivados de 3h-quinazolin-4-ona como inhibidores de mao-b
GT199900011A (es) Nuevos derivados del acido dihidroxihexanoico
CL2023001220A1 (es) Inhibidores de interleucina-17
ECSP045277A (es) Composición oftálmica que comprende ascomicina

Legal Events

Date Code Title Description
FB Suspension of granting procedure